Hims Hers Health is trading 6.9% down at $28.19 as investors lock in profits following a significant recent rally.
- The decline follows a sharp run-up in recent sessions, including a 7.7% gain on July 27 and notable volatility last week.
- There are no fresh company-specific headlines, earnings reports, or major analyst calls driving today's price action.
- The downward move appears tied to broader market sentiment, with the Nasdaq under pressure and no new fundamental developments for the company.